The University of Siena in Siena, Tuscany, is one of the oldest and first publicly funded universities in Italy. Originally called Studium Senese, the institution was founded in 1240. It had around 20,000 students in 2006, nearly half of Siena's total population of around 54,000.

During the past decade, University of Siena conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Siena" #1 sponsor was "Medtronic Cardiovascular" with 2 trials, followed by "Edison Pharmaceuticals Inc" with 1 trials sponsored, "Gianluca Pontone, MD, PhD" with 1 trials sponsored, "Gianmarco de Donato" with 1 trials sponsored and "Italian Society of Diabetology" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Siena" #1 collaborator was "University of Siena" with 2 trials as a collaborator, "ASST Fatebenefratelli Sacco" with 1 trials as a collaborator, "ASST Santi Paolo e Carlo" with 1 trials as a collaborator, "ASST Spedali Civili, Brescia" with 1 trials as a collaborator and "ASST Valtellina e Alto Lario" with 1 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "University of Siena" are "Abdominal Aortic Aneurysm" (1 trials), "Aortic Aneurysm" (1 trials), "Aortic Aneurysm, Abdominal" (1 trials), "Aorto Iliac Aneurysm" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "University of Siena" in a lesser frequency.

Most popular intervention types in "University of Siena" are "Drug" (5 trials), "Device" (3 trials), "Procedure" (3 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ALTO endograft implantation" (1 trials), "Azacytidine" (1 trials), "EPI-743" (1 trials) and "EndoAnchor™" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Siena" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Siena". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in University of Siena, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Siena, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".